Work

Successful Emulation of IV Decitabine Pharmacokinetics with an Oral Fixed-Dose Combination of the Oral Cytidine Deaminase Inhibitor (CDAi) E7727 with Oral Decitabine, in Subjects with Myelodysplastic Syndromes (MDS): Final Data of Phase 1 Study

Year: 2016

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v128.22.114.114

Authors: Guillermo Garcia-Manero, Olatoyosi Odenike, Philip C. Amrein, David P. Steensma, Amy E. DeZern, Laura C. Michaelis, Stefan Faderl, Hagop M. Kantarjian, James N. Lowder, Pietro Taverna, Aram Oganesian, Xiaoping Zhang, Mohammad Azab, Michael R. Savona

Institutions: The University of Texas MD Anderson Cancer Center, University of Chicago, Massachusetts General Hospital, Dana-Farber Cancer Institute, Johns Hopkins University, Johns Hopkins Hospital, Medical College of Wisconsin, Hackensack University Medical Center, Astex Pharmaceuticals, Vanderbilt University, Vanderbilt-Ingram Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2587592231

FWCI: 3.798

Cites:

Cited by: 16

Related to: 10